Sulggi Lee is an Infectious Disease physician. ClinicalTrials.gov lists 5 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
995 Potrero Ave Bldg 80
San Francisco, CA 941102859
Telephone
415-735-5127Provider last certified this registry record 28 Apr 2026.
Clinical trials
- Short-term Effects of Methamphetamine on Residual Latent HIV Disease Study
Sponsor: University of California, San Francisco
- DISulfiram for COvid-19 (DISCO) Trial
Sponsor: University of California, San Francisco
- Effect of Methamphetamine on Residual Latent HIV Disease Study
Sponsor: University of California, San Francisco
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
44.2%Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor17.7%Triumeq64%Descovy36%Part D<11 patientsProtease Inhibitor12%Darunavir59%Ritonavir41%Part D<11 patients+ 2 more classes in this area
Respiratory
23.3%Opioid Agonist13.1%Hydrocodone-Acetaminophen100%Part D<11 patientsbeta2-Adrenergic Agonist10.2%Ventolin Hfa59%Albuterol Sulfate Hfa41%Part D<11 patientsCardiovascular
21.9%Statin11%Atorvastatin Calcium100%Part D<11 patientsACE inhibitor6.4%Lisinopril100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
8 NIH research awards on record, funded 2014–2026 per NIH RePORTER. The latest:
- In Vivo Imaging and Post-Mortem Study of Methamphetamine Use on Immune Dysfunction and HIV Reservoir Transcription among People with HIV on ART
University of California, San Francisco
FY2026$2,335,360RM1DA063218 - STudy of Acute HIV for investiGating Eradication Strategies (STAGES): The role of IL-10 and IFN signaling
University of California, San Francisco
FY2026$849,912R01AI186774 - In Vivo Imaging and Post-Mortem Study of Methamphetamine Use on Immune Dysfunction and HIV Reservoir Transcription among People with HIV on ART
University of California, San Francisco
FY2025$2,331,737RM1DA063218
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Yousef Khader
Jordan University of Science and Technology
Andrew Rambaut
University of Edinburgh
Olayinka Stephen Ilesanmi
University College Hospital
Maysaa El Sayed Zaki
Mansoura University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”